Scopus Biopharma Inc.
SCPS
Revenue
0.00
0.000.00%
6 Months ChangeAssets
497.55k
▼-1.11M▼-68.97%
3 Months ChangeLiabilities
9.95M
▲1.40M▲16.36%
3 Months ChangeFree Cash Flow
-3.98M
▼-1.18M▼-42.27%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-08-18
Form 8-K
ID: 0001104659-23-093554
2023-08-11
Form 8-K
ID: 0001104659-23-090580
2023-08-11
Form 10-Q
ID: 0001410578-23-001787
2023-05-12
Form 10-Q
ID: 0001410578-23-001110
2022-12-16
Form 8-K
ID: 0001104659-22-127517
2022-12-02
Form 8-K
ID: 0001104659-22-124179
2022-11-21
Form 10-Q
ID: 0001410578-22-003519
2022-10-20
Form 8-K
ID: 0001104659-22-110330
2022-10-19
Form 8-K
ID: 0001104659-22-109870
2022-10-07
Form 8-K
ID: 0001104659-22-107186